New blood filter aims to speed recovery in ICU patients on life support

NCT ID NCT06179771

Recruiting now Disease control Sponsor: University Hospitals, Leicester Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a blood filter called HA380 in 40 critically ill adults (ages 18-65) who need dialysis or ECMO due to severe infection, injury, or major surgery. The filter is added to their life-support circuit to remove inflammatory substances from the blood. Researchers want to see if this approach is practical and whether it reduces time on breathing machines, blood pressure drugs, and in the ICU.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury acute respiratory distress syndrome infectious disease with sepsis Inflammation inflammatory disease injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY INJURY ARDS EXTRACORPOREAL CIRCULATION; COMPLICATIONS INFLAMMATION

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University Hospitals of Leicester NHS Trust
RECRUITING

Leicester, Leicestershire, LE3 9QP, United Kingdom

Contact Email: •••••@•••••

Contact

Contact Email: •••••@•••••